Valrubicin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Valrubicin. Educational only — not medical advice.
Labeled uses
Valrubicin intravesical solution is an anthracycline topoisomerase inhibitor indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality.
Source: FDA labeling via NIH DailyMed (set 8739ae02…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.